The U.S. FDA is fast reversing decisions made under former commissioner Marty Makary, especially those related to rare-disease therapies. Biotechs UniQure (QURE) and Regenxbio (RGNX) have become the ...
Enbridge Pipelines Inc. received permission from Canada’s National Energy Board to proceed with its Line 9B Reversal and Line 9 Capacity Expansion project. NEB approved the project with conditions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results